Yarrow Bioscience Inc
Support and Resistance Levels
Past performance
News About YARW
All events for YARW
All deals for YARW
Financial Ratios
Financial Statements
YARW vs Sector & Peers
About Yarrow Bioscience Inc
Yarrow Bioscience is a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases. The Company's lead product candidate, YB-101, is a potential first-in-class anti-thyroid stimulating hormone receptor (TSHR) monoclonal antibody designed to directly and rapidly disrupt the central mechanism of both Graves' disease (GD) and thyroid eye disease (TED). Website yarrowbioscience.com
Headquarters New Haven, CT, US